Hims & Hers Health Crashes After Novo Nukes GLP-1 Partnership Over “Illegal Mass Compounding” Scheme Shares of Hims & Hers Health crashed in premarket trading after Novo Nordisk terminated its GLP-1 partnership with the telehealth firm, citing violations of federal law related to mass sales of compounded drugs disguised as “personalized” treatments, along with deceptive marketing practices that allegedly jeopardized patient safety. Novo Nordisk terminates collaboration with HIMS, stock plunges — zerohedge (@zerohedge) June 23, 2025 Following the FDA’s resolution of the national Wegovy shortage in April, Novo partnered with select telehealth companies, including Hims & Hers, to transition patients from unregulated, compounded… — Continue at ZeroHedge News : Read More
